» Authors » Nikolaos Fragakis

Nikolaos Fragakis

Explore the profile of Nikolaos Fragakis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 149
Citations 749
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karakasis P, Theofilis P, Patoulias D, Vlachakis P, Antoniadis A, Fragakis N
Int J Mol Sci . 2025 Mar; 26(5). PMID: 40076813
The global rise in diabetes prevalence has significantly contributed to the increasing burden of atherosclerotic cardiovascular disease (ASCVD), a leading cause of morbidity and mortality in this population. Diabetes accelerates...
2.
Karakasis P, Lefkou E, Pamporis K, Farmakis D, Patoulias D, Antoniadis A, et al.
Eur J Heart Fail . 2025 Mar; PMID: 40064512
Aims: Clonal haematopoiesis (CH) is recognized as a significant risk factor for various non-haematologic conditions, including cardiovascular diseases. However, recent studies examining its relationship with heart failure (HF) have reported...
3.
Karakasis P, Fragakis N, Ruza I, Stachteas P, Patoulias D
Future Cardiol . 2025 Mar; :1-4. PMID: 40055143
No abstract available.
4.
Pamporis K, Karakasis P, Sagris M, Theofilis P, Milaras N, Pantelidaki A, et al.
Eur J Prev Cardiol . 2025 Mar; PMID: 40053837
Aim: Asymptomatic atrial fibrillation (AF) is frequent and associated with disease progression. This meta-analysis aimed to estimate the prevalence of asymptomatic AF and identify risk factors associated with asymptomatic status....
5.
Karakasis P, Lefkou E, Patoulias D, Fragakis N
Acta Cardiol . 2025 Feb; :1-2. PMID: 40007154
No abstract available.
6.
Karakasis P, Patoulias D, Fragakis N, Gomez-Huelgas R
Eur J Intern Med . 2025 Feb; PMID: 39986942
No abstract available.
7.
Karakasis P, Patoulias D, Rizzo M, Fragakis N, Mantzoros C
Diabetes Obes Metab . 2025 Feb; PMID: 39950216
Background And Aims: Adequate lipid control has emerged as a key factor in the prevention and management of chronic kidney disease (CKD). Remnant cholesterol (RC), a lipoprotein with an established...
8.
Karakasis P, Theofilis P, Patoulias D, Schuermans A, Vlachakis P, Klisic A, et al.
Eur J Clin Invest . 2025 Jan; e14392. PMID: 39868862
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) commonly leads to heart failure but has traditionally been an exclusion criterion in randomized clinical trials (RCTs) of sodium-glucose cotransporter 2 inhibitors (SGLT2i); therefore, the...
9.
Zormpas G, Karagiannidis E, Apostolidou X, Papadopoulos C, Kassimis G, Fragakis N, et al.
J Invasive Cardiol . 2025 Jan; PMID: 39832273
No abstract available.
10.